Company News

As the Chinese New Year approaches, Vivolight will observe a holiday from February 15 to February 24, 2026. During this time, our response times may be longer than usual, and we sincerely appreciate your patience and understanding. At Vivolight, our mission has always been to support healthcar...

Dubai, Feb. 10, 2026 — WHX Dubai (formerly Arab Health) is in full swing this week at the Dubai Exhibition Centre (DEC), bringing together healthcare innovators, clinicians, and industry partners across the region and beyond. The show floor feels like a live feed of where healthcare is headin...

Dubai, UAE — 9 February 2026 — WHX Dubai (formerly Arab Health) opened today at the Dubai Exhibition Centre (DEC), bringing together 4,300+ exhibitors and healthcare stakeholders representing 180+ countries, with 235k+ professional visits expected across the week (per organizer figures)...

In late 2025, a paper from the preprint platform arXiv has been published and has attracted a lot of attention in the field of cardiovascular intervention community.   The paper reported that a domain-specific medical AI system named CA-GPT—designed to support decision-making during...

  November 17, 2025 Global Tour 2025 · Key Station for European Market Penetration   From November 17 to 20, the world-renowned MEDICA 2025 kicked off grandly in Düsseldorf, Germany. As the "barometer" of the global medical industry, this exhibition gathered over 6,000 exhibi...

On September 20, at the 27th Annual Congress of the Chinese Society of Cardiology, the 23rd Interventional Cardiology Congress, and the 2025 Chang’an Cardiology Congress, the "Symposium on the Application of Artificial Intelligence-OCT (AI-OCT) in PCI Precision Diagnosis and Treatment" was gra...

San Francisco, October 2025 — Transcatheter Cardiovascular Therapeutics (TCT) is one of the world’s leading conferences dedicated to interventional cardiology. The 37th edition of TCT will take place at the Moscone Convention Center in San Francisco from October 25 to 28, 2025. Brin...

A Remarkable Win at the 8th Secret Light Awards   On June 4, 2025, Vivolight Medical won the Cutting-Edge Innovation Award at the 8th Secret Light Awards (SLA) held at Hilton Shenzhen World Exhibition & Convention Center. Its 355 nm cold-laser plaque-ablation system was chosen from among 20...

EuroPCR 2025 concluded with a wave of technological breakthroughs, and Vivolight Medical stood at the forefront with its revolutionary P80 Multimodal Cardiovascular OCT System. As the world’s first FDA-cleared OCT platform featuring integrated AI diagnosis, the P80 attracted global i...

April 11, 2025, Vivolight Medical announced that its independently developed Optical Coherence Tomography (OCT) system has obtained FDA 510(k) clearance. This milestone not only enbale the U.S. market entry, but also streamlines regulatory pathways across 20+ countries recog...

Optical Coherence Tomography (OCT) is revolutionizing modern cardiovascular interventions by providing high-resolution imaging for precise diagnosis and treatment. Recently, RSUD Al-Ihsan Hospital in Bandung, Indonesia, successfully performed two complex coronary interventions utilizing Vivolight OC...

Vivolight Medical’s at Arab Health 2025: Illuminating a New Era of Global Cooperation in the Year of the Snake   From January 27 to January 30, 2025, Vivolight Medical made a dazzling appearance at the global medical technology event—Arab Health 2025, showcasing China&rsqu...